People Directory : Dave Knaack


Dave Knaack

Director, Technology Transfer

Office for Technology Transfer

Office Phone: +1 508 289 3556

» Lab/Group Site

WHOI Mailing Address:

Woods Hole Oceanographic Institution

266 Woods Hole Rd.

MS# 53

Woods Hole, MA 02543-1050

Research Statement


1 10,080,661  

Injectable and moldable bone substitute materials

2 9,993,579   Polyurethanes for osteoimplants 
3 9,789,223   Polyurethanes for osteoimplants 
4 9,333,080   Injectable and moldable bone substitute materials 
5 9,327,052   Polyurethanes for osteoimplants 
6 9,107,751   Injectable and moldable bone substitute materials 
7 8,771,719   Synthesis of a bone-polymer composite material 
8 8,740,987   Tissue-derived mesh for orthopedic regeneration 
9 8,686,064   Coupling agents for orthopedic biomaterials 
10 8,545,864   Hemostatic bone graft 
11 8,425,893   Polyurethanes for osteoimplants 
12 8,333,985   Non-glycerol stabilized bone graft 
13 8,002,843   Polyurethanes for osteoimplants 
14 7,985,414   Polyurethanes for osteoimplants 
15 7,959,941   Bone graft comprising a demineralized bone matrix and a stabilizing agent 
16 7,270,813   Coupling agents for orthopedic biomaterials 
17 7,163,691   Bone graft 
18 6,599,516   Malleable implant containing solid element that resorbs or fractures to provide access channels 
19 5,773,255   Glucose responsive insulin secreting .beta.-cell lines and method for producing same 
20 5,712,159   Glucose responsive insulin secreting .beta.-cell lines and method for producing same 
21 5,534,404   Glucose responsive insulin secreting .beta.-cell lines and method for producing same 

Personal Statement

David Knaack, Ph.D. joined WHOI in 2013 as the Director for Technology Transfer with responsibilities for Commercializing New Technologies arising from WHOI’s relationship with the sea. In addition to marketing and licensing of new technologies, his role includes identifying, patenting and facilitating applied research for product advancement

Dr. Knaack joined WHOI after 24 years in the Medical Device/Biotech industry where he held leadership positions in Product Development and Research, most recently as Vice President of Product Development & Manufacturing at ORTHOCON/ABYRX, Inc.  His roles in four biomedical startups have given him a breadth of experience in product development, quality systems, regulatory, project management and the strategic development and commercialization of intellectual property.  His areas of technical expertise include: implantable medical devices, biomaterials and composites, biologically active molecules, polymer-tissue composites, and cell line development. He has expertise in a number of therapeutic areas including Diabetes, neurodegeneration, orthopedics, analgesia and hemostasis. Dr. Knaack has peer reviewed publications in the fields of biocomposites, biomaterials, tissue engineering and cell and molecular biology. He is is a registered patent agent, a named inventor on twenty issued U.S. patents, and agent of record on two others. He holds a B.Sci. in Chemistry from St. Lawrence University and a Ph.D. in Neurochemistry from Cornell University. He completed post-doctoral work in Molecular Biology at Harvard Medical School as a Howard Hughes Fellow.